MiR-200b expression in breast cancer: A prognostic marker and act on cell proliferation and apoptosis by targeting Sp1

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 4, 2015, Pages 760-769

  Yao, Yasai ^a   Hu, Jian ^b   Shen, Zan ^c   Yao, Ruyong ^a   Liu, Shihai ^a   Li, Yong ^a   Cong, Hui ^a   Wang, Xingang ^a   Qiu, Wensheng ^a   Yue, Lu ^a  

^a QINGDAO UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Breast cancer; Cell growth; MiR 200b; Prognosis; Sp1

Indexed keywords

3' UNTRANSLATED REGION; MICRORNA; MIRN200 MICRORNA, HUMAN; TRANSCRIPTION FACTOR SP1; TUMOR MARKER;

3' UNTRANSLATED REGION; APOPTOSIS; BREAST TUMOR; CANCER STAGING; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KAPLAN MEIER METHOD; MCF-7 CELL LINE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MCF-7 CELLS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR;

EID: 84925945103     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12432     Document Type: Article

References (33)

1. Thun MJ, DeLancey JO, Center MM, et al. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010; 31: 100-10.
2. Davis S, Lollo B, Freier S, et al. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 2006; 34: 2294-304.
3. Costa PM, Pedroso de Lima MC. MicroRNAs as molecular targets for cancer therapy: on the modulation of MicroRNA expression. Pharmaceuticals. 2013; 6: 1195-220.
4. Shi XB, Tepper CG, deVere White RW. Cancerous miRNAs and their regulation. Cell Cycle. 2008; 7: 1529-38.
5. Reis LO, Pereira TC, Lopes-Cendes I, et al. MicroRNAs: a new paradigm on molecular urological oncology. Urology. 2010; 76: 521-7.
6. Chou J, Shahi P, Werb Z. microRNA-mediated regulation of the tumor microenvironment. Cell Cycle. 2013; 12: 3262-71.
7. Fang YX, Gao WQ. Roles of microRNAs during prostatic tumorigenesis and tumor progression. Oncogene. 2014; 33: 135-47.
8. Iorio MV, Casalini P, Tagliabue E, et al. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer. 2008; 44: 2753-9.
9. Hannafon BN, Sebastiani P, de las Morenas A, et al. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res. 2011; 13: R24.
10. Song B, Wang C, Liu J, et al. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res. 2010; 29: 29.
11. Li S, Meng H, Zhou F, et al. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract. 2013; 209: 179-83.
12. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10: 593-601.
13. Iliopoulos D, Lindahl-Allen M, Polytarchou C, et al. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell. 2010; 39: 761-72.
14. Yang S, Li Y, Gao J, et al. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene. 2013; 32: 4294-303.
15. Hu G, Chen D, Li X, et al. miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther. 2010; 10: 190-7.
16. Li W, Lebrun DG, Li M. The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma. Chin J Cancer. 2011; 30: 540-50.
17. Bai JX, Yan B, Zhao ZN, et al. Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines. Endocrinology. 2013; 154: 635-45.
18. Mongroo PS, Rustgi AK. The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther. 2010; 10: 219-22.
19. Katoh M, Igarashi M, Fukuda H, et al. Cancer genetics and genomics of human FOX family genes. Cancer Lett. 2013; 328: 198-206.
20. Zhang SZ, Pan FY, Xu JF, et al. Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo. Mol Cancer Ther. 2005; 4: 1577-84.
21. Yi B, Piazza GA, Su X, et al. MicroRNA and cancer chemoprevention. Cancer Prev Res (Phila). 2013; 6: 401-9.
22. Zhang JX, Song W, Chen ZH, et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol. 2013; 14: 1295-306.
23. Heinzelmann J, Unrein A, Wickmann U, et al. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases. Ann Surg Oncol. 2014; 21: 1046-54.
24. Leskela S, Leandro-Garcia LJ, Mendiola M, et al. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer. 2011; 18: 85-95.
25. Tang H, Deng M, Tang Y, et al. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res. 2013; 19: 5602-12.
26. Zaravinos A, Radojicic J, Lambrou GI, et al. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer. J Urol. 2012; 188: 615-23.
27. Jovanovic M, Hengartner MO. miRNAs and apoptosis: RNAs to die for. Oncogene. 2006; 25: 6176-87.
28. Perruisseau-Carrier C, Jurga M, Forraz N, et al. miRNAs stem cell reprogramming for neuronal induction and differentiation. Mol Neurobiol. 2011; 43: 215-27.
29. Roybal JD, Zang Y, Ahn YH, et al. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res. 2011; 9: 25-35.
30. Peng B, Hu S, Jun Q, et al. MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma. Mol Cell Biochem. 2013; 379: 51-8.
31. Yan GZ, Ziff EB. Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J Neurosci. 1997; 17: 6122-32.
32. Kolesnikoff N, Attema JL, Roslan R, et al. Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition. J Biol Chem. 2014; 289: 11194-205.
33. Solomon SS, Majumdar G, Martinez-Hernandez A, et al. A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones. Life Sci. 2008; 83: 305-12.